Lucene search

K
cve[email protected]CVE-2017-17678
HistoryMay 19, 2021 - 2:15 p.m.

CVE-2017-17678

2021-05-1914:15:07
CWE-79
web.nvd.nist.gov
17
cve-2017-17678
bmc remedy
mid tier
9.1sp3
xss
cross-site scripting
dom-based
vulnerability

4.3 Medium

CVSS2

Attack Vector

NETWORK

Attack Complexity

MEDIUM

Authentication

NONE

Confidentiality Impact

NONE

Integrity Impact

PARTIAL

Availability Impact

NONE

AV:N/AC:M/Au:N/C:N/I:P/A:N

6.1 Medium

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality Impact

LOW

Integrity Impact

LOW

Availability Impact

NONE

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

0.001 Low

EPSS

Percentile

47.8%

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Affected configurations

NVD
Node
bmcremedy_mid-tierMatch9.1sp3

4.3 Medium

CVSS2

Attack Vector

NETWORK

Attack Complexity

MEDIUM

Authentication

NONE

Confidentiality Impact

NONE

Integrity Impact

PARTIAL

Availability Impact

NONE

AV:N/AC:M/Au:N/C:N/I:P/A:N

6.1 Medium

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality Impact

LOW

Integrity Impact

LOW

Availability Impact

NONE

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

0.001 Low

EPSS

Percentile

47.8%

Related for CVE-2017-17678